Novel enabling technologies for vaccine development. 26-27 January 1999, Royal Society, London, UK.
This was a very well-organized meeting with a highly attractive program featuring some of the leading people in current vaccine development. A special focus was given to novel adjuvant research and the possibility of developing combination vaccines. Close to 150 participants from academia and industry gathered in the excellent conference center of the Royal Society and the two-day sessions were superbly chaired by Professor Myron Levine, (Center for Vaccine Development (CVD), University of Maryland, Baltimore, USA) and Dr Ronald Ellis (BioChem Pharma Inc, Boston, MA, USA).